Concourse Financial Group Securities, Inc. Gt Biopharma, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share
Q4 2023 Feb 07, 2024	BUY	$0.22 - $0.28 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.24 - $0.35 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.24 - $0.35 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.22 - $0.55 $0 - $0
Q1 2023 May 15, 2023	BUY	$0.46 - $1.05 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.89 - $58.2 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.81 - $56.1 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.64 - $3.11 $0 - $0
Q1 2022 May 09, 2022	BUY	$2.6 - $3.3 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$3.05 - $7.08 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$6.68 - $15.26 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$7.19 - $18.96 $0 - $0
Q1 2021 May 13, 2021	BUY	$4.4 - $8.84 $0 - $0

Others Institutions Holding GTBP

# of Institutions

Shares Held

564

Call Options Held

Put Options Held

View Full List

About GT Biopharma, Inc.

Ticker GTBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,557,700
Market Cap $96.4M
Description
GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...

More about GTBP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account